Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
78,800
-1,000 (-1.25%)
At close: Mar 28, 2025, 3:30 PM KST

KRX:185750 Revenue

In the year 2024, Chong Kun Dang Pharmaceutical had annual revenue of 1.59T KRW, down -4.97%. Chong Kun Dang Pharmaceutical had revenue of 415.36B in the quarter ending December 31, 2024, a decrease of -17.69%.

Revenue
1,586.43B
Revenue Growth
-4.97%
P/S Ratio
0.66
Revenue / Employee
697.03M
Employees
2,276
Market Cap
1,038.27B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,586.43B-82.97B-4.97%
Dec 31, 20231,669.40B181.06B12.17%
Dec 31, 20221,488.34B144.79B10.78%
Dec 31, 20211,343.56B40.55B3.11%
Dec 31, 20201,303.01B223.67B20.72%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition